Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms
- 29 June 2018
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 63 (10) , 2673-2680
Abstract
Due to concerns about long-term PPI use in patients with acid reflux, we aimed at minimizing PPI use, either by avoiding initiating therapy, downscaling to other therapies, or introducing endoscopic or surgical options.Keywords
This publication has 29 references indexed in Scilit:
- Update on the epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut, 2013
- Burden of Gastrointestinal Disease in the United States: 2012 UpdateGastroenterology, 2012
- Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapyDiseases of the Esophagus, 2012
- Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitorsGut, 2012
- Randomised clinical trial: a comparison between a GerdQ‐based algorithm and an endoscopy‐based approach for the diagnosis and initial treatment of GERDAlimentary Pharmacology & Therapeutics, 2012
- Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond StudyGut, 2010
- Esophageal Pressure Topography Criteria Indicative of Incomplete Bolus Clearance: A Study Using High-Resolution Impedance ManometryAmerican Journal of Gastroenterology, 2009
- Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of TherapyGastroenterology, 2009
- Burden of Digestive Diseases in the United States Part I: Overall and Upper Gastrointestinal DiseasesGastroenterology, 2009
- American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux DiseaseGastroenterology, 2008